Medicare Enrolled

Dr. Viki Forlano, MD

Family Medicine · San Angelo, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
4235 SUNSET DR, San Angelo, TX 76904
3254812197
In practice since 2005 (20 years)
NPI: 1376547216 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Forlano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Forlano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Forlano

Dr. Viki Forlano is a family medicine in San Angelo, TX, with 20 years in practice. Based on federal Medicare data, Dr. Forlano performed 6,257 Medicare services across 1,656 unique beneficiaries.

Between the years covered by Open Payments, Dr. Forlano received a total of $5,932 from 34 pharmaceutical and/or device companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Forlano is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 2% volume in TX$ $5,932 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,257
Medicare services
Top 2% in TX for family medicine
1,656
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~313 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)3,480$18$33
Blood draw (venipuncture)743$8$8
Office visit, established patient (30-39 min)504$78$217
Office visit, established patient (20-29 min)264$56$149
Hemoglobin A1c test (diabetes monitoring)240$9$58
Annual wellness visit, follow-up179$126$230
Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes154$31$108
Drug injection, under skin or into muscle120$11$50
Home visit, established patient, low complexity85$52$164
Flu vaccine, high-dose75$61$63
Flu vaccine administration75$17$17
Nursing facility visit, low complexity54$46$135
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit35$156$330
Transitional care management services for problem of high complexity27$214$439
Pneumonia vaccine administration25$27$50
Transitional care management services for problem of at least moderate complexity24$158$311
Comprehensive metabolic blood panel19$10$67
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment18$143$316
Lipid panel (cholesterol and triglycerides)17$13$81
Office visit, established patient (10-19 min)17$23$88
Electrocardiogram (EKG), 12-lead15$10$87
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use14$241$529
Injection, methylprednisolone acetate, 40 mg14$5$12
Office visit, established patient, complex (40-54 min)13$122$284
Free thyroxine (T4) test12$8$59
Complete blood count (CBC) with differential12$8$34
Urinalysis, manual11$3$19
Pneumococcal vaccine, 23-valent11$131$190
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,932
Total received (2018-2024)
Avg $847/year across 7 years
Top 11% in TX for family medicine
34
Companies
270
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,152 (70.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,560 (26.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$220 (3.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$474
2023
$289
2022
$1,724
2021
$1,009
2020
$954
2019
$669
2018
$813

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,260
AstraZeneca Pharmaceuticals LP
$561
GlaxoSmithKline, LLC.
$543
Janssen Pharmaceuticals, Inc
$526
Lilly USA, LLC
$354
Amgen Inc.
$351
Amarin Pharma Inc.
$279
SANOFI-AVENTIS U.S. LLC
$257
Novo Nordisk Inc
$227
Boehringer Ingelheim Pharmaceuticals, Inc.
$199
Novartis Pharmaceuticals Corporation
$174
Takeda Pharmaceuticals U.S.A., Inc.
$115
PFIZER INC.
$95
Biohaven Pharmaceuticals, Inc.
$84
Allergan, Inc.
$83
Radius Health, Inc.
$81
AbbVie Inc.
$78
ARBOR PHARMACEUTICALS, INC.
$74
ABBVIE INC.
$70
Astellas Pharma US Inc
$61
MAYNE PHARMA INC.
$59
Merck Sharp & Dohme Corporation
$55
Allergan Inc.
$53
Biohaven Pharmaceutical Holding Company Ltd.
$49
Kowa Pharmaceuticals America, Inc.
$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$37
Biogen, Inc.
$35
Sumitomo Pharma America, Inc.
$25
Esperion Therapeutics, Inc.
$20
ITI, Inc.
$19
Exact Sciences Corporation
$17
Medicure Pharma Inc.
$15
Xeris Pharmaceuticals, Inc.
$14
Genentech USA, Inc.
$13
Top 3 companies account for 39.9% of total payments
Associated products mentioned in payments ›
ADUHELM · AIRSUPRA · ANORO ELLIPTA · AREXVY · Aimovig · BELSOMRA · BEXSERO · BREZTRI · BYDUREON · CAPLYTA · CHANTIX · Cologuard Collection Kit · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · GEMTESA · GVOKE PFS · INVOKANA · JANUVIA · JARDIANCE · LINZESS · Livalo · MAVYRET · MOUNJARO · MYRBETRIQ · NEXLETOL · NURTEC ODT · Otezla · Ozempic · PREVNAR - 13 · PREVNAR 20 · Prolia · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SYMBICORT · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · VIBERZI · VRAYLAR · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · Xofluza · ZEPBOUND · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $95 per 100 Medicare services performed
Looking for a family medicine in San Angelo?
Compare family medicines in the San Angelo area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
57
Per 100K population
47.7
County median income
$66,254
Nearest hospital
RIVER CREST HOSP
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Forlano is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 11%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Forlano experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Forlano performed 3,480 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Forlano receive payments from pharmaceutical companies?
Yes. Dr. Forlano received a total of $5,932 from 34 companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Forlano's costs compare to other family medicines in San Angelo?
Dr. Forlano's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Forlano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →